Literature DB >> 30173403

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system.

Ya Li1, Weifeng Zhang1, Junli Zhao1, Sai Li1, Linlin Shan1, Jiuling Zhu1, Yan Li1, He Zhu1, Qinwen Mao2, Haibin Xia3.   

Abstract

The clustered regulatory interspersed short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) system has been widely used for gene knock-out. Lentiviral vectors have been commonly used as a delivery method for this system, however, prolonged Cas9/sgRNA expression due to lentiviral integration can lead to accumulating off-target mutations. To solve this issue in engineering a gene knock-out cell line, this study established a novel system, which was composed of two lentiviral vectors. One lentiviral vector carried simultaneously sgRNAs and CRISPR/Cas9 expression cassettes targeting single or multiple gene(s); the other lentiviral vector carried Cre that could remove excess sgRNAs and Cas9 expression cassettes in the genome after gene targeting was achieved. To prove the principle, two candidate genes, extracellular matrix protein 1 (ECM1) and progranulin (PGRN), both highly expressed in MDA-MB-231 cells, were selected for testing the novel system. A dual knock-out of ECM1 and PGRN was successfully achieved in MDA-MB-231 cell line, with the sgRNAs and Cas9 expression cassettes being removed by Cre. This system should have great potential in applications for multiple genes knock-out in vitro.

Entities:  

Keywords:  CRISPR/Cas9; Gene editing; Lentivirus; Loxp/Cre system; Off-target

Year:  2018        PMID: 30173403      PMCID: PMC6269370          DOI: 10.1007/s10616-018-0252-2

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  46 in total

1.  Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

Authors:  Ming-Jie Li; James Kim; Shirley Li; John Zaia; Jiing-Kuan Yee; Joseph Anderson; Ramesh Akkina; John J Rossi
Journal:  Mol Ther       Date:  2005-08-22       Impact factor: 11.454

2.  Genome-scale CRISPR-Cas9 knockout screening in human cells.

Authors:  Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

3.  Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.

Authors:  Jon E Walker; Rachel X Chen; Jeannine McGee; Catherine Nacey; Richard B Pollard; Mehrdad Abedi; Gerhard Bauer; Jan A Nolta; Joseph S Anderson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

5.  Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.

Authors:  Aviva Joseph; Jian Hua Zheng; Ken Chen; Monica Dutta; Cindy Chen; Gabriela Stiegler; Renate Kunert; Antonia Follenzi; Harris Goldstein
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

6.  Use of lentiviral vectors to deliver and express bicistronic transgenes in developing chicken embryos.

Authors:  Susan L Semple-Rowland; Jonathan Berry
Journal:  Methods       Date:  2013-06-28       Impact factor: 3.608

7.  Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells.

Authors:  Jing Liao; Rahul Karnik; Hongcang Gu; Michael J Ziller; Kendell Clement; Alexander M Tsankov; Veronika Akopian; Casey A Gifford; Julie Donaghey; Christina Galonska; Ramona Pop; Deepak Reyon; Shengdar Q Tsai; William Mallard; J Keith Joung; John L Rinn; Andreas Gnirke; Alexander Meissner
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

8.  CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells.

Authors:  Richard Moore; Alec Spinhirne; Michael J Lai; Samantha Preisser; Yi Li; Taek Kang; Leonidas Bleris
Journal:  Nucleic Acids Res       Date:  2014-12-18       Impact factor: 16.971

9.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

10.  Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4.

Authors:  Jing Chang; Li Tang; Han Lei; Xiao-Gang Zhang; Zhong Zuo; Wei Huang; Hang Fu
Journal:  Mol Med Rep       Date:  2014-08-21       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.